These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15699365)

  • 21. Environmental mediation and the twin design.
    Purcell S; Koenen KC
    Behav Genet; 2005 Jul; 35(4):491-8. PubMed ID: 15971029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase C677T genotype and PD.
    de Lau LM; Koudstaal PJ; van Meurs JB; Uitterlinden AG; Hofman A; Breteler MM
    Ann Neurol; 2005 Jun; 57(6):927-30. PubMed ID: 15929053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study design options in evaluating gene-environment interactions: practical considerations for a planned case-control study of pediatric leukemia.
    Goodman M; Dana Flanders W
    Pediatr Blood Cancer; 2007 Apr; 48(4):375-9. PubMed ID: 16874764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A note of caution on correlation between sibling pairs.
    de la Fuente-Fernández R
    Neurology; 2003 May; 60(9):1561; author reply 1561. PubMed ID: 12743265
    [No Abstract]   [Full Text] [Related]  

  • 25. [The investigation of gene-environment interaction using case-control comparisons].
    Kellen E; Zeegers MP; Vandenbroucke JP; Buntinx F
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):977-82. PubMed ID: 15903038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple genetic tests for susceptibility to smoking do not outperform simple family history.
    Gartner CE; Barendregt JJ; Hall WD
    Addiction; 2009 Jan; 104(1):118-26. PubMed ID: 19133896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased power to detect gene-environment interaction using siblings controls.
    Andrieu N; Dondon MG; Goldstein AM
    Ann Epidemiol; 2005 Oct; 15(9):705-11. PubMed ID: 16157257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design options for case-control studies of gene-environment interactions.
    Cheng C
    Pediatr Blood Cancer; 2007 Apr; 48(4):373-4. PubMed ID: 16917907
    [No Abstract]   [Full Text] [Related]  

  • 29. TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study.
    Xu C; Li PP; Cooke RG; Parikh SV; Wang K; Kennedy JL; Warsh JJ
    Bipolar Disord; 2009 Feb; 11(1):1-10. PubMed ID: 19133961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic association studies: from "searching under the lamppost" to "fishing in the pond".
    El-Serag HB; White DL; Mitra N
    Gastroenterology; 2008 Mar; 134(3):662-4. PubMed ID: 18325382
    [No Abstract]   [Full Text] [Related]  

  • 32. Family history of melanoma and Parkinson disease risk.
    Mascitelli L; Pezzetta F; Goldstein MR
    Neurology; 2010 Apr; 74(17):1397. PubMed ID: 20421588
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimating interaction between genetic and environmental risk factors: efficiency of sampling designs within a cohort.
    Bureau A; Diallo MS; Ordovas JM; Cupples LA
    Epidemiology; 2008 Jan; 19(1):83-93. PubMed ID: 18091418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are Parkinson disease patients protected from some but not all cancers?
    Inzelberg R; Jankovic J
    Neurology; 2007 Oct; 69(15):1542-50. PubMed ID: 17699801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical designs for familial aggregation.
    Liang KY; Beaty TH
    Stat Methods Med Res; 2000 Dec; 9(6):543-62. PubMed ID: 11308070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological studies: risk factors session IV summary and research needs.
    Gorel JM; Checkoway H
    Neurotoxicology; 2001 Dec; 22(6):837-44. PubMed ID: 11829418
    [No Abstract]   [Full Text] [Related]  

  • 37. Case-control design: making the case.
    Fletcher AE
    Am J Ophthalmol; 2010 Apr; 149(4):540-2. PubMed ID: 20346775
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: "Choosing a retrospective design to assess joint genetic and environmental contributions to risks".
    Amre D; Fortier I
    Am J Epidemiol; 2001 Jan; 153(2):205-6. PubMed ID: 11159168
    [No Abstract]   [Full Text] [Related]  

  • 39. Observational etiologic research. Part 4--Matching in case-control studies: almost always a bad idea.
    Middelburg RA; Wiersum-Osselton JC; van de Watering LM; van der Bom JG
    Transfusion; 2014 Feb; 54(2):267-70. PubMed ID: 24117702
    [No Abstract]   [Full Text] [Related]  

  • 40. Case-control study design: spurious associations between exposure and outcome.
    Garabrant DH
    J Occup Environ Med; 2007 Sep; 49(9):941-2. PubMed ID: 17848849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.